International
-
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy
24 June 2021
An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.
-
Bristol researcher wins prestigious diabetes research award
26 July 2017
A University of Bristol researcher whose own family has been affected by diabetes has just been awarded £587,237 from leading charity Diabetes UK to find out why people with Type 2 diabetes are more likely to develop some cancers.
-
GW4 takes a world leading One Health approach to tackling the antimicrobial resistance pandemic
17 June 2021
The GW4 Alliance (Bath, Bristol, Cardiff and Exeter universities – GW4) formally launched their new ‘One Health’ antimicrobial resistance research consortium this week [Wednesday 16 June]. The World Health Organisation cites antimicrobial resistance (AMR) as one of the most significant risks facing the world. AMR threatens global health and development as it impacts on human, animal and plant health and also our environment, water safety and food security.
-
Global climate dynamics drove the decline of mastodonts and elephants, new study suggests
1 July 2021
Elephants and their forebears were pushed into wipeout by waves of extreme global environmental change, rather than overhunting by early humans, according to new research.
-
How have vaccines helped to protect the world and how can they continue to do so?
16 June 2021
The power of vaccines to help save lives and shape our world has never been more evident as countries around the world fight against COVID-19. The pandemic has also highlighted how vital it is for industry, academia and global populations to work together in the race for effective vaccines. The importance of vaccine research to global public health will be discussed later this week by a distinguished panel of experts at a live online event jointly organised by the University of Bristol and Pfizer.
-
UK faces post-pandemic bereavement crisis and lasting legacy of grief
15 June 2021
New research has highlighted the difficulties and distress people experienced when trying to get support after the death of a loved one during the pandemic, with more than half of people (51 per cent) experiencing high or severe vulnerability in their grief and those seeking support facing long waiting lists or being told they are ineligible.
-
Bristol graduates among highest paid in the UK
16 June 2017
Graduates of the University of Bristol are among the highest paid in the country three years after graduating, according to data released by the Department of Education.
-
HIV has detrimental effect on children’s growth and bone strength, finds landmark study
14 June 2021
Children growing up with HIV infection have concerning deficits in skeletal strength which become more apparent towards the end of pubertal growth, finds the largest study to date to investigate the link between HIV and skeletal health in children. The study, conducted in Zimbabwe and published in The Lancet Child and Adolescent Health, identifies a link between these skeletal deficits and the first-line antiretroviral-HIV drug, tenofovir disproxil fumarate (TDF), which is widely used across sub-Saharan Africa.
-
Dental procedures are very low risk in the aerosol spread of COVID-19, study finds
14 June 2021
Many of the common procedures carried out by dentists have very low risk of increasing the aerosol spread of COVID-19 and some procedures, such as ultrasonic scaling, were not shown to generate aerosol other than from the clean instrument itself, new research has found.
-
Adrenal gland activity change under severe stress causing abnormal release of glucocorticoid stress hormones
18 July 2017
To respond to stress optimally, the body needs to produce glucocorticoid hormones, such as cortisol, extremely quickly. New research by scientists from the Universities of Bristol and Exeter has revealed the molecular network that enables rapid glucocorticoid production within the adrenal glands, and has shown how the behaviour of this network can be altered under severe stress.
View the for public events and lectures run by the University.